| [1] |
Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.
Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer
[J]. Journal of International Oncology, 2024, 51(6): 321-325.
|
| [2] |
Liu Jing, Liu Qin, Huang Mei.
Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm
[J]. Journal of International Oncology, 2024, 51(5): 267-273.
|
| [3] |
He Jiahui, Hu Qinyong.
Comparative analysis of lung cancer incidence and mortality trends and risk factors in China and the United States based on GBD data
[J]. Journal of International Oncology, 2024, 51(1): 29-36.
|
| [4] |
Zhao Xin, Fan Xuewu, Tian Long, Hu Yimin.
Application and evaluation study of 3D ultrasound in image guided radiotherapy for prostate cancer
[J]. Journal of International Oncology, 2024, 51(1): 43-49.
|
| [5] |
Deng Juanjun, Zhao Dayong, Li Miao.
Adverse reactions and risk factors of immune checkpoint inhibitors in the treatment of non-small cell lung cancer
[J]. Journal of International Oncology, 2023, 50(9): 564-568.
|
| [6] |
Yang Lirong, Wang Yufeng.
Construction of machine learning models for predicting the risk of postoperative distant metastasis recurrence in serous ovarian cancer
[J]. Journal of International Oncology, 2023, 50(4): 220-226.
|
| [7] |
Yang Jun, Li Rong, Zeng Jianchang.
Clinical efficacy of Compound Kushen Injection combined with SOX regimen in the treatment of elderly patients with advanced gastric cancer
[J]. Journal of International Oncology, 2023, 50(2): 82-86.
|
| [8] |
Zuo Xiaoping, Liu Xiaochuan, Wu Xiqiang, Li Zhou, Xia Tian, Liu Guofeng.
Risk factors and prediction model construction of arrhythmia in elderly patients with early lung cancer after thoracoscopic pulmonary resection
[J]. Journal of International Oncology, 2023, 50(12): 711-716.
|
| [9] |
Jiao Panpan, Xue Lijuan, Zhan Juan.
Risk factors and predictors of immune-related adverse events induced by immune checkpoint inhibitors
[J]. Journal of International Oncology, 2023, 50(12): 739-744.
|
| [10] |
Chen Yu, Xu Hua, Liu Hai, Chen Shixin.
Construction of pathological classification prediction model for malignant pulmonary pure ground-glass nodule patients based on CT imaging
[J]. Journal of International Oncology, 2023, 50(11): 655-660.
|
| [11] |
Yang Sha, Yang Xiaohua, Wang Suhua, Xue Xiaoyan, Xu Jun.
Analysis of risk factors for deep vein thrombosis of lower extremity after thoracoscopic surgery for elderly lung cancer and establishment and validation of prediction model
[J]. Journal of International Oncology, 2022, 49(9): 532-536.
|
| [12] |
Chen Huangjing, Zhu Pengfei, Zhang Qing, Chen Guifang, Yang Chunlin, He Ying.
Comparative study on the clinical value of contrast-enhanced ultrasound- and CT-guided percutaneous puncture biopsy in peripheral lung masses
[J]. Journal of International Oncology, 2022, 49(8): 459-463.
|
| [13] |
Zhang Yan, Pan Lei, Liu Shuting.
Establishment of an efficacy prediction model for gefitinib in non-small cell lung cancer patients based on ABCB1 and ABCG2 gene polymorphisms
[J]. Journal of International Oncology, 2022, 49(6): 327-333.
|
| [14] |
Cai Gangxiang, Li Jing, Xu Bin.
Advances in neoadjuvant immunotherapy for lung cancer
[J]. Journal of International Oncology, 2022, 49(6): 366-370.
|
| [15] |
Zhang Jingxian, Yi Dan, Li Xiaojiang.
Application of antibody-drug conjugates in the treatment of non-small cell lung cancer
[J]. Journal of International Oncology, 2022, 49(5): 296-301.
|
